This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical ...

A patient has died after receiving the high dose of Neurogene’s Rett syndro | A patient has died after receiving the high ...

Siren Biotechnology's Approach Could Transform the High-Grade Glioma Therapy Landscape "SRN-101 has the potential to address ...

Delivering very large genes to cells can pose a serious challenge, so scientists developed a new method. | Genetics And ...

Researchers have developed a dual-gene therapy approach to treat Usher syndrome type 1F, a rare condition causing deafness and progressive blindness.

A serious adverse event in the New York biotech’s phase 1/2 trial of its Rett syndrome gene therapy puts a question mark over ...

Currently, VYGR’s pipeline includes four in-house programs and 14 partnered programs backed by the TRACER technology that ...

It delivers a functional copy of the F9 gene directly to the liver cells using an adeno-associated virus (AAV) vector. Once ...

William Blair analyst Sami Corwin has maintained their bullish stance on RCKT stock, giving a Buy rating on November 15.Don't Miss our Black ...

Jason Zemansky, an analyst from Bank of America Securities, reiterated the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The ...